LAYANSON PHARMA LTD

🇬🇧Vereinigtes Königreich•Private Limited Company (Ltd.)•Aktiv

Nettomarge (2025)Nettomarge

-10,4 %

Betriebsmarge (2025)Betriebsmarge

14,3 %

Fremdkapital zu Eigenkapital (2024)Fremdkapital zu Eigenkapital

Zusammenfassung

LandVereinigtes Königreich

StatusAktiv

Handelsregisternummer14632770

Gegründet1.2.2023

ZweckGroßhandel mit pharmazeutischen Waren; Apotheken; Sonstige humanmedizinische Tätigkeiten

Adresse3 Bramley Road, Thornbury, BS35 1EY

BestätigungserklärungNächste Fälligkeit: —; Zuletzt erstellt: —

Recht & Status

RechtsformPrivate Limited Company (Ltd.)

StatusAktiv

Registrierungsdatum1.2.2023

RegistergerichtCompanies House

Stammkapital—

Quelle: UK Companies House · Zuletzt aktualisiert: 3.12.2025

Timeline (7 Ereignisse)

31.10.2025

Jahresabschluss eingereicht

Total exemption full accounts made up to 28 February 2025

Datei in Dokumente anzeigen

28.2.2025

Jahresabschluss eingereicht

Annual Accounts · Geschäftsjahr bis 28.2.2025

Datei in Dokumente anzeigen

1.2.2023

Bestellt Adedamola Layade (Person)

Bestellt als Director

Kennzahl	2024	2025
Umsatz	—	£686.635
Gewinn / (Verlust)	—	£-71.639
Bruttogewinn	—	£285.291
Betriebsgewinn	—	£97.922
Sonstige Erträge	—	£149
Gesamtvermögen	£209.000	£-21.542
Net Assets Liabilities	£58.397	£58.397
Equity	£58.397	£-21.542
Current Assets	£337.972	£337.972
Net Current Assets Liabilities	£41.114	£41.114
Total Assets Less Current Liabilities	£379.258	£379.258
Cash Bank On Hand	£23.318	£23.318
Debtors	£284.654	£284.654
Other Debtors	£16.556	£16.556
Creditors	£296.858	£281.608
Trade Creditors Trade Payables	£148.721	£148.721
Other Creditors	£94.341	£94.341
Issue Equity Instruments	—	£1
Average Number Employees During Period	10	10
Verwaltungskosten	—	£187.369
Accumulated Amortisation Impairment Intangible Assets	£27.867	£69.667
Accumulated Depreciation Impairment Property Plant Equipment	£24.156	£50.838
Additions Other Than Through Business Combinations Property Plant Equipment	£181.167	£80.807
Bank Borrowings	£281.608	£281.608
Bank Overdrafts	£53.694	£53.694
Cost Sales	—	£401.344
Dividends Paid	—	£8.300
Finance Lease Liabilities Present Value Total	—	£57.637
Fixed Assets	£338.144	£338.144
Gross Profit Loss	—	£285.291
Increase From Amortisation Charge For Year Intangible Assets	£27.867	£41.800
Increase From Depreciation Charge For Year Property Plant Equipment	£24.156	£26.682
Intangible Assets	£181.133	£181.133
Intangible Assets Gross Cost	£209.000	£209.000
Interest Payable Similar Charges Finance Costs	—	£273
Operating Profit Loss	—	£97.922
Other Interest Receivable Similar Income Finance Income	—	£149
Profit Loss On Ordinary Activities Before Tax	—	£97.649
Property Plant Equipment	£157.011	£157.011
Property Plant Equipment Gross Cost	£181.167	£261.974
Provisions For Liabilities Balance Sheet Subtotal	£39.253	£39.253
Taxation Social Security Payable	£102	£102
Tax Tax Credit On Profit Or Loss On Ordinary Activities	—	£39.253
Total Additions Including From Business Combinations Intangible Assets	£209.000	—
Total Inventories	£30.000	£30.000
Trade Debtors Trade Receivables	£268.098	£268.098
Turnover Revenue	—	£686.635

Kennzahl

2024

2025

Umsatz

—

£686.635

Gewinn / (Verlust)

—

£-71.639

Bruttogewinn

—

£285.291

Betriebsgewinn

—

£97.922

Sonstige Erträge

—

£149

Gesamtvermögen

£209.000

£-21.542

Net Assets Liabilities

£58.397

Equity

£58.397

£-21.542

Current Assets

£337.972

Net Current Assets Liabilities

£41.114

Total Assets Less Current Liabilities

£379.258

Cash Bank On Hand

£23.318

Debtors

£284.654

Other Debtors

£16.556

Creditors

£296.858

£281.608

Trade Creditors Trade Payables

£148.721

Other Creditors

£94.341

Issue Equity Instruments

—

£1

Average Number Employees During Period

Verwaltungskosten

—

£187.369

Accumulated Amortisation Impairment Intangible Assets

£27.867

£69.667

Accumulated Depreciation Impairment Property Plant Equipment

£24.156

£50.838

Additions Other Than Through Business Combinations Property Plant Equipment

£181.167

£80.807

Bank Borrowings

£281.608

Bank Overdrafts

£53.694

Cost Sales

—

£401.344

Dividends Paid

—

£8.300

Finance Lease Liabilities Present Value Total

—

£57.637

Fixed Assets

£338.144

Gross Profit Loss

—

£285.291

Increase From Amortisation Charge For Year Intangible Assets

£27.867

£41.800

Increase From Depreciation Charge For Year Property Plant Equipment

£24.156

£26.682

Intangible Assets

£181.133

Intangible Assets Gross Cost

£209.000

Interest Payable Similar Charges Finance Costs

—

£273

Operating Profit Loss

—

£97.922

Other Interest Receivable Similar Income Finance Income

—

£149

Profit Loss On Ordinary Activities Before Tax

—

£97.649

Property Plant Equipment

£157.011

Property Plant Equipment Gross Cost

£181.167

£261.974

Provisions For Liabilities Balance Sheet Subtotal

£39.253

Taxation Social Security Payable

£102

Tax Tax Credit On Profit Or Loss On Ordinary Activities

—

£39.253

Total Additions Including From Business Combinations Intangible Assets

£209.000

—

Total Inventories

£30.000

Trade Debtors Trade Receivables

£268.098

Turnover Revenue

—

£686.635

Name	Beteiligung	Stimmrecht	Seit

Name	Beteiligung	Land	Seit

LAYANSON PHARMA LTD

Zusammenfassung

Recht & Status

Timeline (7 Ereignisse)

Jahresabschluss eingereicht

Jahresabschluss eingereicht

Bestellt Adedamola Layade (Person)

Netzwerk

Eigentum & Führung

Persons with significant control

Officers & directors

Eigentümer-Timeline (1 Änderungen)

Bestellt Adedamola Layade (Person)

Aktionäre

Wirtschaftlich Berechtigter

Geografie

Finanzen

Kennzahlen

Dokumente

Unternehmensbericht von LAYANSON PHARMA LTD

Confirmation statement

Registration of particulars of charge

Registration of particulars of charge

Total exemption full accounts made up to 28 February 2025

Companexia Document AI

Confirmation statement

Annual Accounts

Total exemption full accounts made up to 29 February 2024

Registration of particulars of charge

Annual Accounts

Weitere Unternehmen & Personen durchsuchen

Finanzielle Kennzahlen

Margen

Wachstum

Effizienz & Rendite

Working Capital & Liquidität

Forderungen & Verbindlichkeiten

Kapitalstruktur

Qualität & Mix